334 results
Page 5 of 17
8-K
EX-99.1
crs8 7hq9f
27 Jul 22
Other Events
7:30am
424B5
brlq vgpq
22 Jul 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-10.1
oduz2dat
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
8-K
EX-99.1
46tjlcvfh
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
8-K
EX-99.1
in5fla9bana
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
EX-99.1
1vll73993c qeua4ibx
16 May 22
Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
fr6f2iineb
4 May 22
Other Events
4:33pm
8-K
EX-99.1
k9j7adsn
18 Apr 22
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
4:25pm
8-K
EX-99.1
yws5hmbw2fzhyt0i
12 Apr 22
Diffusion Pharmaceuticals Completes Dosing in Altitude Trial
9:08am
DEFA14A
EX-99.1
pu62vf
8 Apr 22
Additional proxy soliciting materials
5:05pm
8-K
EX-99.1
djx0xdgsiafmxqk
8 Apr 22
Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders
5:04pm
8-K
EX-99.1
2hr4ub4q5znjldah9tbi
21 Mar 22
Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Update
4:26pm
8-K
EX-10.1
tyxbfj00
18 Mar 22
Entry into a Material Definitive Agreement
5:14pm